Low Fecal Calprotectin Predicts Histological Healing in Patients with Ulcerative Colitis with Endoscopic Remission and Leads to Prolonged Clinical Remission (vol 29, pg 359, 2023)

被引:0
|
作者
Kawashima, Kousaku
Oshima, Naoki
Kishimoto, Kenichi
Kataoka, Masatoshi
Fukunaga, Mai
Kotani, Satoshi
Sonoyama, Hiroki
Oka, Akihiko
Mishima, Yoshiyuki
Kazumori, Hideaki
Ishikawa, Noriyoshi
Araki, Asuka
Ishihara, Shunji
机构
关键词
D O I
10.1093/ibd/izad261
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:2013 / 2013
页数:1
相关论文
共 50 条
  • [31] HISTOLOGICAL REMISSION USING A NANCY INDEX OF 0 IS ASSOCIATED WITH LONGER RELAPSE-FREE SURVIVAL THAN HISTOLOGICAL ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS IN CLINICAL AND ENDOSCOPIC REMISSION
    Pudipeddi, Aviv
    Fung, Caroline
    Kariyawasam, Viraj
    Paramsothy, Ramesh
    Ghaly, Simon
    Haifer, Craig
    An, Yoon
    Begun, Jakob
    Connor, Susan
    Chetwood, John
    Paramsothy, Sudarshan
    Leong, Rupert
    GUT, 2022, 71 : A149 - A150
  • [32] Histological remission using a Nancy index of 0 is associated with longer relapse-free survival than histological activity in patients with ulcerative colitis in clinical and endoscopic remission
    Pudipeddi, A.
    Fung, C.
    Kariyawasam, V.
    Paramsothy, R.
    Ghaly, S.
    Haifer, C.
    An, Y.
    Begun, J.
    Connor, S.
    Chetwood, J.
    Paramsothy, S.
    Leong, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 170 - 170
  • [33] Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse
    Asuka Nakarai
    Jun Kato
    Sakiko Hiraoka
    Shiho Takashima
    Daisuke Takei
    Toshihiro Inokuchi
    Yuusaku Sugihara
    Masahiro Takahara
    Keita Harada
    Hiroyuki Okada
    World Journal of Gastroenterology, 2016, (21) : 5079 - 5087
  • [34] Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse
    Nakarai, Asuka
    Kato, Jun
    Hiraoka, Sakiko
    Takashima, Shiho
    Takei, Daisuke
    Inokuchi, Toshihiro
    Sugihara, Yuusaku
    Takahara, Masahiro
    Harada, Keita
    Okada, Hiroyuki
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (21) : 5079 - 5087
  • [35] Ulcerative Colitis Patients in Clinical Remission Demonstrate Correlations Between Fecal Immunochemical Test Results, Mucosal Healing, and Risk of Relapse
    Nakarai, Asuka
    Kato, Jun
    Hiraoka, Sakiko
    Takashima, Shiho
    Takei, Daisuke
    Inokuchi, Toshihiro
    Sugihara, Yuusaku
    Takahara, Masahiro
    Harada, Keita
    Okada, Hiroyuki
    Yamamoto, Kazuhide
    GASTROENTEROLOGY, 2015, 148 (04) : S194 - S194
  • [36] Vedolizumab Induces Clinical Response and Remission Across a Range of Baseline Fecal Calprotectin Levels in Patients with Ulcerative Colitis: Results from GEMINI 1
    Wyant, Tim
    Lewis, James
    Reinisch, Walter
    Dassopoulos, Emistocles
    Ginsburg, Philip
    Sands, Bruce
    Feagan, Brian
    Danese, Silvio
    Roseth, Arne
    Rosario, Maria
    Yang, Huyuan
    Parikh, Asit
    Bressler, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S486 - S486
  • [37] Efficacy of Beclomethasone Dipropionate in Lowering Fecal Calprotectin Levels in Patients with Ulcerative Colitis in Clinical Remission and at Risk of Relapse: The Becalcu Randomized, Controlled Trial
    Ginard, Daniel
    Barreiro-de Acosta, Manuel
    Nos, Pilar
    Moraleja, Irene
    Munoz Nunez, Fernando
    Aldeguer, Xavier
    Echarri, Ana
    Villoria, Albert
    Riestra, Sabino
    Bosca Watts, Marta Maia
    Gonzalez-Lama, Yago
    Royo, Vanesa
    Ferreiro-Iglesias, Rocio
    Iborra, Marisa
    Elorza, Ainara
    Fernandez-Pordomingo, Alejandra
    Sans, Miquel
    DIGESTIVE DISEASES, 2024, 42 (06) : 600 - 609
  • [38] Clinical, endoscopic and histological remission in paediatric chronically active ulcerative colitis after prolonged treatment with selective granulocyte-monocyte adsorptive apheresis
    Martin-Carpi, Javier
    Varea, Vicente
    JOURNAL OF CROHNS & COLITIS, 2009, 3 (03): : 216 - 217
  • [39] COMPARISON OF PROSTAGLANDIN E-MAJOR URINARY METABOLITE (PGE-MUM) WITH FECAL CALPROTECTIN AND FECAL IMMUNOCHEMICAL TESTS FOR DETERMINING ENDOSCOPIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS.
    Sakurai, Toshiyuki
    Akita, Yoshihiro
    Miyashita, Haruna
    Miyazaki, Ryosuke
    Maruyama, Yuki
    Shimada, Mariko
    Saito, Tomoko
    Kato, Tomohiro
    Saruta, Masayuki
    Yamasaki, Takuji
    GASTROENTEROLOGY, 2020, 158 (06) : S708 - S708
  • [40] FECAL CALPROTECTIN AFTER 3 MONTHS OF ANTI-TNF THERAPY STRONGLY PREDICTS PROLONGED CLINICAL REMISSION IN PATIENTS WITH CROHN'S DISEASE
    Sollelis, Elisa
    Minet-Quinard, Regine
    Bouguen, Guillaume
    Goutte, Marion
    Goutorbe, Felix
    Bouvier, Damien
    Pereira, Bruno
    Bommelaer, Gilles
    Buisson, Anthony
    GASTROENTEROLOGY, 2018, 154 (06) : S825 - S826